Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rohto V5 is a functional dietary supplement developed by Rohto Pharmaceutical, specifically formulated to support eye health and maintain visual function, particularly in aging populations. Categorized as a 'Food with Function Claims' (FFC) in Japan, it contains the carotenoids lutein and zeaxanthin as its primary active ingredients. These compounds are naturally occurring pigments that accumulate in the macula of the eye, where they function by increasing macular pigment optical density. This increase helps protect the retina from oxidative stress and filters harmful blue light, thereby improving contrast sensitivity and supporting the maintenance of clear vision. Launched in 2015, Rohto V5 is administered orally, typically in the form of a softgel capsule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rohto V5.